DOWNLOAD the newest Prep4King ALS-Con-201 PDF dumps from Cloud Storage for free: https://drive.google.com/open?id=1WZBJuVwMn0_FzkpE6XuLWDibIdFT5FTn
The key trait of our product is that we keep pace with the changes the latest circumstance to revise and update our ALS-Con-201 study materials, and we are available for one-year free updating to our customers. Our company has established a long-term partnership with those who have purchased our ALS-Con-201 exam guides. We have made all efforts to update our product in order to help you deal with any change, making you confidently take part in the exam. We will inform you that the ALS-Con-201 Study Materials should be updated and send you the latest version of our ALS-Con-201 exam questions in a year after your payment.
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
>> ALS-Con-201 Reliable Test Answers <<
With all ALS-Con-201 practice questions being brisk in the international market, our ALS-Con-201 exam materials are quite catches with top-ranking quality. But we do not stop the pace of making advancement by following the questions closely according to exam. So our experts make new update as supplementary updates. So that our ALS-Con-201 study braindumps are always the latest for our loyal customers and we will auto send it to you as long as we update it.
NEW QUESTION # 113
Choose 1 option.
Cumulus Pharma uses Agentforce Life Sciences for Customer Engagement Sprints to manage two-week execution cycles. Key Account Managers (KAMs) are marking their sprints as "Finished" in the picklist, but the system does not recognize them as closed for reporting purposes. The picklist value must map to the system state.
Where should the Agentforce Life Sciences Consultant configure this mapping?
Answer: A
Explanation:
The correct answer is B because sprint completion values are configured in the Life Sciences Admin Console under Key Account Management sprint settings. Salesforce Help for Configure Sprint Completion Statuses states that administrators should go to the App Launcher, open Admin Console, select Key Account Management, and then select Sprints Settings in the left navigation pane. From there, admins add the sprint values that indicate completion.
The scenario says KAMs are selecting a picklist value called "Finished," but the system does not recognize the sprint as closed for reporting. That means the label exists as a picklist option, but it has not been mapped as a completion status in the Life Sciences Key Account Management sprint configuration. The consultant must configure the completion-status mapping in Sprint Settings so the platform treats "Finished" as a closed/completed sprint value.
Option A is too broad and does not point to the specific sprint completion configuration. Option C is also incorrect because editing the Status picklist in Object Manager only changes or adds picklist values. It does not tell the Life Sciences Key Account Management logic which values count as completed for reporting and process behavior. Therefore, the mapping should be configured in Admin Console > Key Account Management > Sprint Settings.
=========
NEW QUESTION # 114
Choose 1 option.
Cumulus Pharma enforces Chain of Custody protocols for its restricted product, Immunexis. During an in-person field visit, a field sales rep physically hands over five sample packs to a Healthcare Provider (HCP). To adhere to regulatory compliance and generate the required electronic receipt for this transaction, the rep must finalize the disbursement record in the Agentforce Life Sciences mobile app.
Which required action must the rep take to complete this physical custody transfer?
Answer: A
Explanation:
The correct answer is B because physical sample disbursement to an HCP requires compliant signature capture to confirm the handoff and support the audit trail. Salesforce's Life Sciences Customer Engagement data model states that Provider Visit Management supports compliance requirements for sample eligibility, sample limits, allocations, and e-signature capture. Salesforce also describes Electronic Signatures through Digital Verifications as the way to set up signature trails for records or workflows that require users to verify key updates.
In this scenario, the field sales rep is physically transferring custody of a restricted product to the HCP. To finalize that disbursement and generate the required electronic receipt, the rep must capture the HCP's digital signature directly on the mobile device. This ties the transaction to the HCP, the product, the quantity, the timestamp, and the specific disbursement event.
Option A is incorrect because an Inventory Adjustment is used to reconcile inventory discrepancies or administrative stock changes, not to document a compliant HCP sample handoff. Option C is also incorrect because a confirmation email is not the standard Life Sciences sample-disbursement action for chain-of-custody compliance. The required mobile action is direct digital signature capture from the HCP.
=========
NEW QUESTION # 115
Choose 1 option.
Cumulus Pharma requires strict governance over its Healthcare Provider (HCP) master data to ensure regulatory compliance. Any changes to critical compliance fields, such as Medical License Number, must be routed to a Data Steward for verification and approval.
What should the Agentforce Life Sciences Consultant recommend?
Answer: C
Explanation:
Option B is correct because Salesforce Life Sciences Cloud provides a standard Data Change Requests framework for governed master-data updates. The requirement is not simply to block a change or create a manual task; it is to route critical HCP data changes to a Data Steward for review before the change is applied. Salesforce's Life Sciences Cloud Account Management documentation describes Data Change Requests as a capability used to validate data changes by objects and fields and configure data changes by profile and record type. That aligns directly with controlled governance over fields such as Medical License Number.
The specific configuration object in the question, LifeSciDataChgPersonaDef, represents the persona-based data-change configuration. Salesforce's Developer Guide identifies LifeSciDataChgPersonaDef as part of Data Change Requests and includes the ChangeUpdateType picklist field. Setting ChangeUpdateType to DoNotApplyChangesImmediately means changes are not applied directly by the sales rep persona and can instead be managed through the data-change governance process.
Option A is not the best answer because a custom record-triggered flow would duplicate standard Life Sciences Cloud data-change governance and could create maintenance or compliance risk. Option C is also not ideal because a validation rule only blocks the update; it does not create the governed change-request process needed for Data Steward review. Salesforce's Data Change Requests data model includes Life Science Data Change Definition, managed fields, record types, persona definitions, and Life Science Data Change Request, confirming this is the intended standard architecture.
=========
NEW QUESTION # 116
Choose 1 option.
Cumulus Pharma wants to roll out Tableau Next to provide its field sales team with real-time performance insights, such as "Visit Plan Attainment," directly within the Agentforce Life Sciences mobile app. The relevant Metrics have been created, the Tableau View component has been added to the Mobile Home Page Lightning record page, and the metadata cache has been refreshed. However, when a field sales rep logs in to the app, the Metrics component displays an error indicating insufficient privileges and the metrics do not load.
Which Tableau Next permission set should the Agentforce Life Sciences Consultant assign to resolve this issue?
Answer: B
Explanation:
The correct answer is C because field sales reps only need to view and consume Tableau Next metrics in the Life Sciences mobile app. Salesforce Help for Tableau Next in Life Sciences Cloud explains that Tableau Next integrates with Life Sciences Cloud to provide actionable insights and enhanced visualizations. Salesforce's Tableau Next permission guidance also identifies Tableau Next Consumer as the permission set used for viewing Tableau Next content and interacting with metrics, while creator-level access is intended for users who create and manage Tableau Next assets.
In this scenario, the technical setup has already been completed: the metrics exist, the Tableau View component has been placed on the Mobile Home Page Lightning record page, and the mobile metadata cache has been refreshed. The remaining issue is an insufficient-privileges error, which indicates that the user lacks the Tableau Next permissions required to load and consume the metric. Assigning Tableau Next Consumer grants the field rep the appropriate access level without giving unnecessary authoring privileges.
Option A, Tableau Next Creator, is incorrect because field sales reps are not creating or administering metrics; they only need to consume them. Option B, CRM Analytics Plus User, is also incorrect because the requirement is specifically for Tableau Next metrics, not legacy CRM Analytics access. Therefore, the consultant should assign the Tableau Next Consumer permission set.
=========
NEW QUESTION # 117
Choose 1 option.
Cumulus Pharma wants to ensure that whenever a field sales rep discusses a product during a visit, for example "Immunexis," the rep is required to record product-specific information before being allowed to submit the visit.
How should the Agentforce Life Sciences Consultant configure this requirement?
Answer: B
Explanation:
Option C is correct because the requirement is product-specific and should be configured through Product Discussion Settings, not through a generic page-layout or Visit validation rule. Salesforce's Life Sciences Cloud Visit Management data model includes Provider Visit Product Discussion as the object that represents products discussed during a visit, including key details about the product brand, therapeutic area, and related information. Salesforce also documents ProviderVisitProdDiscussion as representing additional notes or information about products discussed during a healthcare provider visit.
The question asks for a configuration that applies when a specific product, such as Immunexis, is discussed. Enabling Require Discussion in Product Discussion Settings for the product record is the most targeted standard configuration because it ties the requirement to that product's visit discussion behavior.
Option A is not the best answer because a custom validation rule on Visit would have to inspect related product-discussion records and could become complex or unreliable for mobile visit submission behavior. Option B is also insufficient because making a Comments field required on the page layout would apply based on the layout, not specifically when Immunexis is discussed. It also would not necessarily enforce product-specific discussion requirements across all relevant visit submission paths. Therefore, the consultant should enable Require Discussion in Product Discussion Settings for the Immunexis product record.
=========
NEW QUESTION # 118
......
Prep4King is a website specifically provide the certification exam information sources for Salesforce professionals. Through many reflects from people who have purchase Prep4King's products, Prep4King is proved to be the best website to provide the source of information about ALS-Con-201 Certification Exam. The product of ALS-Con-201 is a very reliable training tool for you. The answers of the exam exercises provided by Prep4King is very accurate. Our Prep4King's senior experts are continuing to enhance the quality of our training materials.
ALS-Con-201 Exam Experience: https://www.prep4king.com/ALS-Con-201-exam-prep-material.html
DOWNLOAD the newest Prep4King ALS-Con-201 PDF dumps from Cloud Storage for free: https://drive.google.com/open?id=1WZBJuVwMn0_FzkpE6XuLWDibIdFT5FTn